Наукова електронна бібліотека
періодичних видань НАН України

A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer

Репозиторій DSpace/Manakin

Показати простий запис статті

dc.contributor.author Yazici, O.
dc.contributor.author Aksoy, S.
dc.contributor.author Ozdemir, N.
dc.contributor.author Sendur, M.A.N.
dc.contributor.author Dogan, M.
dc.contributor.author Zengin, N.
dc.date.accessioned 2019-01-20T08:27:21Z
dc.date.available 2019-01-20T08:27:21Z
dc.date.issued 2013
dc.identifier.citation A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer / O. Yazici, S. Aksoy, N. Ozdemir, M.A.N. Sendur, M. Dogan, N. Zengin // Experimental Oncology. — 2013. — Т. 35, № 4. — С. 311-312. — Бібліогр.: 6 назв. — англ. uk_UA
dc.identifier.issn 1812-9269
dc.identifier.uri http://dspace.nbuv.gov.ua/handle/123456789/145266
dc.description.abstract Aim: Facioscapulohumeral muscular dystrophy (FSHD) is an autosomally inherited neuromuscular disorder and may be associated with increased cancer risk. Patient: A 69-year old female admitted to hospital with complaint of left axillary mass who had diagnosis of FSHD in her adulthood period. Results: Bilateral breast cancer diagnosis was made and the patient underwent bila­teral mastectomy. Following the operation, adjuvant chemotherapy and radiotherapy performed and hormonal therapy started. Conclusion: The patients with congenital muscular dystrophy might have an increased risk of malignancy. We consider that some genetic alterations in FSHD might have contributed to the development of bilateral breast cancer in our patient. Key Words: muscular dystrophy, breast cancer, PTEN.Aim: Facioscapulohumeral muscular dystrophy (FSHD) is an autosomally inherited neuromuscular disorder and may be associated with increased cancer risk. Patient: A 69-year old female admitted to hospital with complaint of left axillary mass who had diagnosis of FSHD in her adulthood period. Results: Bilateral breast cancer diagnosis was made and the patient underwent bila­teral mastectomy. Following the operation, adjuvant chemotherapy and radiotherapy performed and hormonal therapy started. Conclusion: The patients with congenital muscular dystrophy might have an increased risk of malignancy. We consider that some genetic alterations in FSHD might have contributed to the development of bilateral breast cancer in our patient. uk_UA
dc.language.iso en uk_UA
dc.publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України uk_UA
dc.relation.ispartof Experimental Oncology
dc.subject Special issue on breast cancer uk_UA
dc.title A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer uk_UA
dc.type Article uk_UA
dc.status published earlier uk_UA


Файли у цій статті

Ця стаття з'являється у наступних колекціях

Показати простий запис статті

Пошук


Розширений пошук

Перегляд

Мій обліковий запис